Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 11, Issue 9, 1996, Pages 1781-1786

  Hruby, M ^a   Urena P ^a   Mannstadt, M ^a   Schmitt, F ^a   Lacour, B ^a   Drucke T B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Calcitriol; Plasma calcium; Plasma phosphorus; Secondary hyperparathyroidism; Uraemia; Vitamin D analogues

Indexed keywords

20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; CALCITRIOL; EB 1213; GS 1725; PARATHYROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ANIMAL EXPERIMENT; ARTERIAL BLOOD; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; HYPERCALCEMIA; HYPERPHOSPHATEMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEPHRECTOMY; NONHUMAN; PARATHYROID FUNCTION; PRIORITY JOURNAL; RAT; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0029795252     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.9.1781     Document Type: Article

References (17)

1. Fournier A, Drüeke T, Morinière Ph et al. The new treatments of hyperparathyroidism secondary to renal insufficiency. Adv Nephrol 1992; 21: 237-306
2. Bikle DD. Clinical counterpoint: vitamin D: new actions, new analogues, new therapeutic potential. Endocrinol Rev 1992; 13: 765-784
3. Bouillon R, Allewaert K, Xiang DZ, Tan BK, Baelen Hv. Vitamin D analogues with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity. J Bone Miner Res 1991; 6: 1051-1057
4. Zhou LX, Norman AW. 1α,25(OH)2-vitamin D3 analogue structure function assessment of intestinal nuclear receptor occupancy with induction of calbindin-D28K. Endocrinology 1995; 136: 1145-1152
5. Brown AJ, Ritter CR, Finch JL et al. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J Clin Invest 1991; 84: 728-732
6. Fukagawa M, Kaname S-Y, Igarashi T, Ogata E, Kurokawa K. Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int 1991; 39: 874-881
7. Kubrusly M, Gagné E-R, Ureña P et al. Effect of 22-oxacalcitriol on calcium metabolism in rats with severe secondary hyperparathyroidism. Kidney Int 1993; 44: 551-556
8. Kurokawa K, Azikawa T, Suzuki M, Akiba T, Ogata E, Slatopolsky E. Preliminary observations on the use of 22-oxacalcitriol in dialysis patients (Abstract). In: Llach F. ed. Renal Bone Disease, Parathyroid Hormone and Vitamin D Seville, Spain, 1995, Abstract Book, p. 1
9. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989; 320: 980-991
10. Szabo A, Merke J, Beier E, Mall G, Ritz E. 1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 1989; 35: 1045-1056
11. Kremer R, Bolivar I, Goltzman D, Hendy GN. Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 1989; 125: 935-941
12. Binderup L. Comparison of calcipotriol with selected metabolites and analogues of vitamin D3: effects on cell growth regulation in vitro and calcium metabolism in vivo. Pharmacol Toxicol 1993; 72: 240-244
13. Christiansen C, Rodbro P, Christiansen MS, Hartnack B, Transbol IB. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol. Lancet 1978; 2: 700-708
14. Baker LRJ, Abram S, Roe C, Faugere MC, Malluche H. 1,25 (OH)2 vitamin D3 administration in moderate renal failure: a prospective double blind trial. Kidney Int 1989; 35: 661-669
15. Fukuda N, Tanaka H, Tominaga Y et al. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1442
16. Fukagawa M, Fukuda N, Yi H, Kurokawa K. Resistance of the parathyroid cell to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure. Nephrol Dial Transplant 1995; 10: 316-319
17. Arnold A, Brown MF, Ureña P et al. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95: 2047-2054